- $57.09m
- $37.02m
- $0.20m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.428 | 0.576 | 0.203 | 0.199 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 0 | 0 | 0.038 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.12 | 4.5 | 5.33 | 7.55 | 10.6 |
Operating Profit | -3.12 | -4.07 | -4.76 | -7.34 | -10.4 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.12 | -7.79 | -4.77 | -7.19 | -9.95 |
Net Income After Taxes | -3.12 | -7.79 | -4.77 | -7.19 | -9.95 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.93 | -7.79 | -4.77 | -7.19 | -9.95 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.93 | -7.79 | -4.77 | -7.19 | -9.95 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.89 | -2.2 | -0.819 | -1.17 | -1.61 |